Fatty acid binding protein 4 deficiency protects against oxygen-induced retinopathy in mice

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Saint Geniez, Magali ^a   Ghelfi, Elisa ^b   Liang, Xiaoliang ^b   Yu, Chenwei ^b   Spencer, Carrie ^a   Abend, Stephanie ^a   Hotamisligil, Gokhan ^c   Cataltepe, Sule ^b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN 4; FABP4 PROTEIN, MOUSE; FATTY ACID BINDING PROTEIN; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOTHELIUM CELL; EYE DEVELOPMENT; EYE PROTECTION; MACROPHAGE FUNCTION; MICROGLIA; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETINOPATHY; UPREGULATION; ANIMAL; C57BL MOUSE; DEFICIENCY; GENETICS; METABOLISM; PATHOLOGY; RETINA BLOOD VESSEL; RETROLENTAL FIBROPLASIA;

ANIMALS; FATTY ACID-BINDING PROTEINS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; RETINAL VESSELS; RETINOPATHY OF PREMATURITY;

EID: 84900448691     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096253     Document Type: Article

References (40)

1. Hartnett ME, Penn JS (2012) Mechanisms and management of retinopathy of prematurity. N Engl J Med 367: 2515-2526. doi:10.1056/NEJMra1208129.
2. Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, et al. (2005) The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics 116: 15-23. doi:10.1542/peds.2004-1413.
3. Wheeler DT, Dobson V, Chiang MF, Bremer DL, Gewolb IH, et al. (2011) Retinopathy of prematurity in infants weighing less than 500 grams at birth enrolled in the early treatment for retinopathy of prematurity study. Ophthalmology 118: 1145-1151. doi:10.1016/j.ophtha.2010.09.031.
4. VanderVeen DK, Bremer DL, Fellows RR, Hardy RJ, Neely DE, et al. (2011) Prevalence and course of strabismus through age 6 years in participants of the Early Treatment for Retinopathy of Prematurity randomized trial. J AAPOS 15: 536-540. doi:10.1016/j.jaapos.2011.07.017.
5. Bremer DL, Rogers DL, Good WV, Tung B, Hardy RJ, et al. (2012) Glaucoma in the Early Treatment for Retinopathy of Prematurity (ETROP) study. J AAPOS 16: 449-452. doi:10.1016/j.jaapos.2012.06.011.
6. Chen J, Smith LEH (2007) Retinopathy of prematurity. Angiogenesis 10: 133-140. doi:10.1007/s10456-007-9066-0. (Pubitemid 46440629)
7. Mintz-Hittner HA, Kennedy KA, Chuang AZ, BEAT-ROP Cooperative Group (2011) Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364: 603-615. doi:10.1056/NEJMoa1007374.
8. Good WV, Palmer EA (2011) Bevacizumab for retinopathy of prematurity. N Engl J Med 364: 2359-authorreply2361-2. doi:10.1056/NEJMc1103460#SA1.
9. Saint-Geniez M, Maharaj ASR, Walshe TE, Tucker BA, Sekiyama E, et al. (2008) Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors. PLoS ONE 3: e3554. doi:10.1371/journal.pone.0003554.
10. Kurihara T, Westenskow PD, Bravo S, Aguilar E, Friedlander M (2012) Targeted deletion of Vegfa in adult mice induces vision loss. J Clin Invest 122: 4213-4217. doi:10.1172/JCI65157.
11. Patel RD, Blair MP, Shapiro MJ, Lichtenstein SJ (2012) Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity. Arch Ophthalmol 130: 801-802. doi:10.1001/archophthalmol.2011.1802.
12. Jalali S, Balakrishnan D, Zeynalova Z, Padhi TR, Rani PK (2013) Serious adverse events and visual outcomes of rescue therapy using adjunct bevacizumab to laser and surgery for retinopathy of prematurity. The Indian Twin Cities Retinopathy of Prematurity Screening database Report number 5. Arch Dis Child Fetal Neonatal Ed 98: F327-F333. doi:10.1136/archdischild-2012-302365.
13. Sato T, Wada K, Arahori H, Kuno N, Imoto K, et al. (2012) Serum concentrations of bevacizumab (avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity. Am J Ophthalmol 153: 327-333.e1. doi:10.1016/j.ajo.2011.07.005.
14. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, et al. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7: 699-705. doi:10.1038/89076. (Pubitemid 32588026)
15. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, et al. (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 1377-1379. (Pubitemid 26391462)
16. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS (2000) Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141: 3388-3396. doi:10.1210/endo.141.9.7637. (Pubitemid 32269028)
17. Furuhashi M, Tuncman G, Görgün CZ, Makowski L, Atsumi G, et al. (2007) Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature 447: 959-965. doi:10.1038/nature05844. (Pubitemid 46975747)
18. Furuhashi M, Ishimura S, Ota H, Miura T (2011) Lipid chaperones and metabolic inflammation. Int J Inflam 2011: 642612. doi:10.4061/2011/642612.
19. Elmasri H, Karaaslan C, Teper Y, Ghelfi E, Weng M, et al. (2009) Fatty acid binding protein 4 is a target of VEGF and a regulator of cell proliferation in endothelial cells. FASEB J 23: 3865-3873. doi:10.1096/fj.09-134882.
20. Ghelfi E, Karaaslan C, Berkelhamer S, Akar S, Kozakewich H, et al. (2011) Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 45: 550-556. doi:10.1165/rcmb.2010-0376OC.
21. Cataltepe O, Arikan MC, Ghelfi E, Karaaslan C, Ozsurekci Y, et al. (2012) Fatty acid binding protein 4 is expressed in distinct endothelial and nonendothelial cell populations in glioblastoma. Neuropathol Appl Neurobiol 38: 400-410. doi:10.1111/j.1365-2990.2011.01237.x.
22. Elmasri H, Ghelfi E, Yu C-W, Traphagen S, Cernadas M, et al. (2012) Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway. Angiogenesis 15: 457-468. doi:10.1007/s10456- 012-9274-0.
23. Ghelfi E, Yu C-W, Elmasri H, Terwelp M, Lee CG, et al. (2013) Fatty acid binding protein 4 regulates VEGF-induced airway angiogenesis and inflammation in a transgenic mouse model: implications for asthma. American Journal Of Pathology 182: 1425-1433. doi:10.1016/j.ajpath.2012.12.009.
24. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, et al. (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35: 101-111. (Pubitemid 24046832)
25. Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, et al. (2009) Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4: 1565-1573. doi:10.1038/nprot.2009.187.
26. Davies MH, Eubanks JP, Powers MR (2006) Microglia and macrophages are increased in response to ischemia-induced retinopathy in the mouse retina. Mol Vis 12: 467-477.
27. Kataoka K, Nishiguchi KM, Kaneko H, van Rooijen N, Kachi S, et al. (2011) The roles of vitreal macrophages and circulating leukocytes in retinal neovascularization. Invest Ophthalmol Vis Sci 52: 1431-1438. doi:10.1167/iovs.10-5798.
28. Carmeliet PP, Moons LL, Luttun AA, Vincenti VV, Compernolle VV, et al. (2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7: 575-583. doi:10.1038/87904.
29. Saino-Saito S, Nourani R, Iwasa H, Kondo H, Owada Y (2009) Discrete localization of various fatty-acid-binding proteins in various cell populations of mouse retina. Cell Tissue Res 338: 191-201.
30. Yonekura H, Sakurai S, Liu X, Migita H, Wang H, et al. (1999) Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis. J Biol Chem 274: 35172-35178. (Pubitemid 129509573)
31. Deissler HL, Deissler H, Lang GK, Lang GE (2013) Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells. Graefes Arch Clin Exp Ophthalmol 251: 2345-2353. doi:10.1007/s00417-013-2393-5.
32. Kowalczuk L, Touchard E, Omri S, Jonet L, Klein C, et al. (2011) Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy. PLoS ONE 6: e17462-e17462. doi:10.1371/journal.pone.0017462.
33. Cao R, Xue Y, Hedlund E-M, Zhong Z, Tritsaris K, et al. (2010) VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy. Proceedings of the National Academy of Sciences 107: 856-861. doi:10.1073/pnas.0911661107.
34. Zhang L, Yang N, Park J-W, Katsaros D, Fracchioli S, et al. (2003) Tumorderived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res 63: 3403-3412. (Pubitemid 36735901)
35. Thomas M, Augustin HG (2009) The role of the Angiopoietins in vascular morphogenesis. Angiogenesis 12: 125-137. doi:10.1007/s10456-009-9147-3.
36. Feng Y, Wang Y, Pfister F, Hillebrands J-L, Deutsch U, et al. (2009) Decreased hypoxia-induced neovascularization in angiopoietin-2 heterozygous knockout mouse through reduced MMP activity. Cell Physiol Biochem 23: 277-284. doi:10.1159/000218174.
37. Cao H, Sekiya M, Ertunc ME, Burak MF, Mayers JR, et al. (2013) Adipocyte lipid chaperone AP2 is a secreted adipokine regulating hepatic glucose production. Cell Metab 17: 768-778. doi:10.1016/j.cmet.2013.04.012.
38. Girona J, Rosales R, Plana N, Saavedra P, Masana L, et al. (2013) FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway. PLoS ONE 8: e81914. doi:10.1371/journal.-pone.0081914.
39. Kaur C, Rathnasamy G, Ling E-A (2013) Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina. J Neuroimmune Pharmacol 8: 66-78. doi:10.1007/s11481-012-9347-2.
40. Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS (2005) The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem 280: 12888-12895. doi:10.1074/jbc.M413788200.